Valuation: Jamjoom Pharmaceuticals Factory Company

Market Cap 8.18B 2.18B 1.95B 1.79B 1.62B 3.05B 206B 3.11B 21.34B 8.6B 109B 8.01B 344B P/E 2026 *
16.7x
P/E 2027 * 15.1x
Enterprise Value 7.86B 2.09B 1.87B 1.72B 1.56B 2.93B 198B 2.98B 20.49B 8.26B 105B 7.69B 330B EV / Sales 2026 *
4.77x
EV / Sales 2027 * 4.24x
Free-Float
38.61%
Yield 2026 *
3.4%
Yield 2027 * 3.88%

Last Transcript: Jamjoom Pharmaceuticals Factory Company

1 day-2.50%
1 week-1.68%
Current month-2.50%
1 month-7.81%
3 months-14.55%
6 months-24.77%
Current year-17.85%
1 week 116.9
Extreme 116.9
124.3
1 month 116.9
Extreme 116.9
131.7
Current year 116.9
Extreme 116.9
163.7
1 year 116.9
Extreme 116.9
163.7
3 years 102.4
Extreme 102.4
202.4
5 years 66
Extreme 66
202.4
10 years 66
Extreme 66
202.4
Manager TitleAgeSince
Chief Executive Officer 62 2021-05-14
Director of Finance/CFO 62 2013-01-12
Chief Operating Officer 31 2021-08-31
Director TitleAgeSince
Chairman 66 2022-06-18
Director/Board Member 41 2022-06-18
Director/Board Member 65 2022-06-18
Change 5-day change 1-year change 3-year change Capi.($)
-2.50%-1.68%-25.06%+7.84% 2.21B
+0.26%+10.85%+58.16%+144.35% 1,263B
-0.46%+1.90%+45.69%+80.62% 658B
-1.98%+0.79%+36.35%+101.73% 521B
-1.54%+0.18%+53.06%+66.79% 391B
-0.13%+5.80%+80.35%+44.65% 369B
-1.69%+3.17%+32.18%+55.35% 307B
-0.72%+7.83%+12.10%+33.76% 290B
+0.40%+5.08%+57.69%+75.26% 252B
+0.27%+7.52%+39.80%+110.05% 212B
Average -0.85%+5.28%+39.03%+72.04% 426.41B
Weighted average by Cap. -0.59%+6.59%+49.04%+93.79%

Financials

2026 *2027 *
Net sales 1.65B 439M 392M 360M 327M 614M 41.59B 626M 4.3B 1.73B 21.95B 1.61B 69.33B 1.84B 490M 438M 402M 365M 685M 46.41B 699M 4.8B 1.93B 24.49B 1.8B 77.37B
Net income 491M 131M 117M 107M 97.43M 183M 12.38B 186M 1.28B 516M 6.53B 480M 20.63B 540M 144M 129M 118M 107M 201M 13.63B 205M 1.41B 568M 7.19B 529M 22.72B
Net Debt -326M -86.86M -77.55M -71.16M -64.73M -121M -8.22B -124M -850M -343M -4.34B -319M -13.71B -384M -102M -91.35M -83.82M -76.25M -143M -9.69B -146M -1B -404M -5.11B -376M -16.15B
Projected Income Statement - Annual - Jamjoom Pharmaceuticals Factory Company
Logo Jamjoom Pharmaceuticals Factory Company
Jamjoom Pharmaceuticals Factory Company is a Saudi Arabia-based entity which is primarily engaged in manufacturing, production, marketing, and distribution of pharmaceutical products. The Company is organized into two segments which are pharmaceutical products, consumer health products. Pharmaceutical products represent medicines or drugs, and they are essential for the prevention and treatment of diseases, and protection of public health; Consumer health products represent products used to support personal well-being, maintain health, or address specific health-related needs. The activities of the Company include producing human medicines, nutraceuticals, antibiotics, general analgesics, medicines for treatment of cough, allergy, asthma, heart diseases, blood pressure, diarrhea, vomiting, ulcer and acidity, treatment of various skin infections, cancer diseases, eye drops and ointments and cosmeceuticals. The Company operates approximately 7 branches in Saudi Arabia.
Employees
-
Date Price Change Volume
26-11-02 SAR 116.90 -2.50% 40,553
26-11-01 SAR 118.40 -1.25% 11,699
26-10-29 SAR 119.90 -1.72% 22,401
26-10-28 SAR 122.00 +0.25% 34,983
26-10-27 SAR 121.70 +0.58% 109,546
Trader
Investor
Global
Quality
ESG MSCI
B
MarketScreener Ratings - Jamjoom Pharmaceuticals Factory Company
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
116.90SAR
Average target price
152.16SAR
Spread / Average Target
+30.16%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Jamjoom Pharmaceuticals Factory Company
  1. Stock Market
  2. Stocks
  3. 4015 Stock